On June 22, 2020, the American Association for Cancer Research (AACR) presented the first-ever AACR-St. Baldrick’s Foundation Award for Outstanding Achievement in Pediatric Cancer Research to St. Jude Children’s Research Hospital Chief Executive Officer James R. Downing, MD. Dr. Downing (https://www.stjude.org/directory/d/james-downing.html) is also the director of the Molecular Pathology Laboratory at St. Jude Children’s Research Hospital and holds the Donald Pinkel Chair of Childhood Cancer Treatment. Dr. Downing is one of the most esteemed pediatric cancer researchers in the world. With this award, he is being recognized for his revolutionary research efforts dedicated to characterizing the genomics of pediatric cancer to inform the development of better treatments for children afflicted with cancer and for contributing to the creation and implementation of the Pediatric Cancer Genome Project (https://www.stjude.org/research/pediatric-cancer-genome-project.html), which has led to a number of landmark discoveries in the biology of brain tumors, leukemia, cancer of the peripheral nervous system, and tumors of the eye. The AACR-St. Baldrick’s Foundation Award for Outstanding Achievement in Pediatric Cancer Research (https://www.aacr.org/awards/aacr-st-baldricks-foundation-award-for-outstanding-achievement-in-pediatric-cancer-research/) was established in 2019 to recognize major research discoveries in pediatric cancer research and to honor an individual who has significantly contributed to any area of pediatric cancer research, resulting in the fundamental improvement of the understanding and/or treatment of pediatric cancer.
Login Or Register To Read Full Story